University of Nebraska Medical Center, Omaha, Nebraska, USA.
Hasbro Children's Hospital, Warren Alpert Medical School, Providence, Rhode Island, USA.
Acad Emerg Med. 2021 Sep;28(9):1043-1050. doi: 10.1111/acem.14274. Epub 2021 Jun 11.
Variation in bronchiolitis management by race and ethnicity within emergency departments (EDs) has been described in single-center and prospective studies, but large-scale assessments across EDs and inpatient settings are lacking. Our objective is to describe the association between race and ethnicity and bronchiolitis management across 37 U.S. freestanding children's hospitals from 2015 to 2018.
Using the Pediatric Health Information System, we analyzed ED and inpatient visits from November 2015 to November 2018 of children with bronchiolitis 3 to 24 months old. Rates of use for specific diagnostic tests and therapeutic measures were compared across the following race/ethnicity categories: 1) non-Hispanic White (NHW), 2) non-Hispanic Black (NHB), 3) Hispanic, and 4) other. The subanalyses of ED patients only and children < 1 year old were performed. Mixed-effect logistic regression was performed to compare the adjusted odds of receiving specific test/treatment using NHW children as the reference group.
A total of 134,487 patients met inclusion criteria (59% male, 28% NHB, 26% Hispanic). Adjusted analysis showed that NHB children had higher odds of receiving medication associated with asthma (odds ratio [OR] = 1.27, 95% confidence interval [CI] = 1.22 to 1.32) and lower odds of receiving diagnostic tests (blood cultures, complete blood counts, viral testing, chest x-rays; OR = 0.78, 95% CI = 0.75 to 0.81) and antibiotics (OR = 0.58, 95% CI = 0.52 to 0.64) than NHW children. Hispanic children had lower odds of receiving diagnostic testing (OR = 0.94, 95% CI = 0.90 to 0.98), asthma-associated medication (OR = 0.92, 95% CI = 0.88 to 0.96), and antibiotics (OR = 0.74, 95% CI = 0.66 to 0.82) compared to NHW children.
NHB children more often receive corticosteroid and bronchodilator therapies; NHW children more often receive antibiotics and chest radiography. Given that current guidelines generally recommend supportive care with limited diagnostic testing and medical intervention, these findings among NHB and NHW children represent differing patterns of overtreatment. The underlying causes of these patterns require further investigation.
在单中心和前瞻性研究中已经描述了急诊科(EDs)中种族和民族对毛细支气管炎管理的差异,但缺乏对 ED 和住院环境的大规模评估。我们的目的是描述 2015 年至 2018 年间美国 37 家独立儿童医院之间种族和民族与毛细支气管炎管理之间的关联。
使用儿科健康信息系统,我们分析了 2015 年 11 月至 2018 年 11 月期间年龄为 3 至 24 个月患有毛细支气管炎的儿童在 ED 和住院期间的就诊情况。比较了以下种族/族裔类别中特定诊断测试和治疗措施的使用率:1)非西班牙裔白人(NHW),2)非西班牙裔黑人(NHB),3)西班牙裔和 4)其他。仅对 ED 患者和<1 岁的儿童进行了亚分析。使用混合效应逻辑回归比较使用 NHW 儿童作为参考组接受特定测试/治疗的调整后比值比(OR)。
共有 134487 名患者符合纳入标准(男性占 59%,NHB 占 28%,西班牙裔占 26%)。调整分析显示,NHB 儿童使用与哮喘相关的药物的几率更高(OR=1.27,95%置信区间[CI]为 1.22 至 1.32),而接受诊断性检查(血培养、全血细胞计数、病毒检测、胸部 X 线)和抗生素的几率更低(OR=0.78,95%CI 为 0.75 至 0.81)。与 NHW 儿童相比,西班牙裔儿童接受诊断性检查(OR=0.94,95%CI 为 0.90 至 0.98)、与哮喘相关的药物(OR=0.92,95%CI 为 0.88 至 0.96)和抗生素(OR=0.74,95%CI 为 0.66 至 0.82)的几率较低。
NHB 儿童更常接受皮质类固醇和支气管扩张剂治疗;NHW 儿童更常接受抗生素和胸部 X 线检查。鉴于目前的指南通常建议支持性治疗,辅以有限的诊断性检查和医疗干预,NHB 和 NHW 儿童的这些发现代表了过度治疗的不同模式。这些模式的潜在原因需要进一步调查。